We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

135 hedge funds and large institutions have $1.11B invested in Immunogen Inc in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 46 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $8.63M | Put options by funds: $8.36M

8% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 50

4% less funds holding

Funds holding: 141135 (-6)

12% less capital invested

Capital invested by funds: $1.25B → $1.11B (-$148M)

29% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 17

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
135
Holders Change
-6
Holders Change %
-4.26%
% of All Funds
3.92%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
12
Increased
46
Reduced
50
Closed
17
Calls
$8.63M
Puts
$8.36M
Net Calls
+$269K
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
$1.17M -$80.6K -5,243 -6%
CI
52
Cowen Inc
New York
$1.13M +$510K +33,158 +76%
Swiss National Bank
53
Swiss National Bank
Switzerland
$1.08M
PIM
54
Platinum Investment Management
Australia
$1.08M
MLICM
55
Metropolitan Life Insurance Company (MetLife)
New York
$1.02M
Citigroup
56
Citigroup
New York
$1.01M +$338K +21,974 +47%
SGAM
57
Smith Group Asset Management
Texas
$972K -$6.96K -453 -0.7%
Macquarie Group
58
Macquarie Group
Australia
$942K +$84.4K +5,490 +9%
AIG
59
American International Group
New York
$917K -$33.4K -2,172 -3%
NG
60
NatWest Group
United Kingdom
$870K +$85K +5,529 +10%
BG
61
BlackRock Group
United Kingdom
$859K +$63.1K +4,108 +8%
PAM
62
Paradigm Asset Management
New York
$846K -$30.7K -2,000 -3%
Natixis Advisors
63
Natixis Advisors
Massachusetts
$835K +$93.5K +6,082 +12%
American Century Companies
64
American Century Companies
Missouri
$834K +$2.61K +170 +0.3%
BA
65
BlackRock Advisors
Delaware
$808K +$60.9K +3,960 +8%
Allianz Asset Management
66
Allianz Asset Management
Germany
$807K +$231K +15,000 +38%
PPA
67
Parametric Portfolio Associates
Washington
$743K +$83.9K +5,457 +12%
DekaBank Deutsche Girozentrale
68
DekaBank Deutsche Girozentrale
Germany
$731K +$20K +1,300 +3%
VOYA Investment Management
69
VOYA Investment Management
Georgia
$700K
Group One Trading
70
Group One Trading
Illinois
$672K +$393K +25,567 +126%
U
71
UBS
Switzerland
$670K +$279K +18,183 +66%
ProShare Advisors
72
ProShare Advisors
Maryland
$643K -$608K -39,535 -47%
NTCOC
73
Northern Trust Company of Connecticut
Connecticut
$572K -$39.5K -2,570 -6%
TRSOTSOK
74
Teachers Retirement System of the State of Kentucky
Kentucky
$559K +$53.3K +3,470 +10%
TAM
75
Tocqueville Asset Management
New York
$431K

IMGN Hedge Fund Activity: Q4 2013 in Review

135 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2013, worth a combined $1.11B — down 12% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of IMGN and 12 opened new positions — a net loss of 5 holders — while 50 trimmed existing stakes and 46 added.

The largest buyer was ClearBridge Investments, adding an estimated $25M. The largest seller was Fidelity Investments, cutting an estimated $8.9M.

  • 135 institutional investors held Immunogen Inc (IMGN) as of Q4 2013, down from 141 in Q3 2013.
  • Funds reported $1.11B of Immunogen Inc stock for Q4 2013, down 12% quarter-over-quarter.
  • 12 funds opened new Immunogen Inc positions in Q4 2013 and 17 closed out, a net change of -5 holders.
  • The largest Immunogen Inc buyer in Q4 2013 was ClearBridge Investments, an estimated $25M added.
  • The largest Immunogen Inc seller in Q4 2013 was Fidelity Investments, an estimated $8.9M sold.

Based on aggregated 13F filings for Q4 2013.